- Home
- APGE vs OII Comparison
APGE vs OII Comparison
Compare APGE & OII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APGE
- OII
- Stock Information
- Founded
- APGE 2022
- OII 1964
- Country
- APGE United States
- OII United States
- Employees
- APGE N/A
- OII N/A
- Industry
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- OII Oilfield Services/Equipment
- Sector
- APGE Health Care
- OII Energy
- Exchange
- APGE Nasdaq
- OII Nasdaq
- Market Cap
- APGE 2.3B
- OII 2.7B
- IPO Year
- APGE 2023
- OII N/A
- Fundamental
- Price
- APGE $34.55
- OII $22.53
- Analyst Decision
- APGE Strong Buy
- OII Hold
- Analyst Count
- APGE 5
- OII 5
- Target Price
- APGE $83.50
- OII $28.20
- AVG Volume (30 Days)
- APGE 514.4K
- OII 688.2K
- Earning Date
- APGE 03-04-2025
- OII 02-19-2025
- Dividend Yield
- APGE N/A
- OII N/A
- EPS Growth
- APGE N/A
- OII 51.58
- EPS
- APGE N/A
- OII 1.44
- Revenue
- APGE N/A
- OII $2,661,161,000.00
- Revenue This Year
- APGE N/A
- OII $9.79
- Revenue Next Year
- APGE N/A
- OII $6.95
- P/E Ratio
- APGE N/A
- OII $15.65
- Revenue Growth
- APGE N/A
- OII 9.75
- 52 Week Low
- APGE $32.46
- OII $19.68
- 52 Week High
- APGE $72.29
- OII $30.98
- Technical
- Relative Strength Index (RSI)
- APGE 35.39
- OII 30.03
- Support Level
- APGE $32.46
- OII $24.69
- Resistance Level
- APGE $37.42
- OII $26.11
- Average True Range (ATR)
- APGE 2.17
- OII 0.89
- MACD
- APGE -0.30
- OII -0.16
- Stochastic Oscillator
- APGE 20.84
- OII 4.79
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Its two programs are APG777 and APG808, which initially develop for treating AD and COPD, respectively.
About OII Oceaneering International Inc.
Oceaneering International Inc is a global provider of engineered services and products robotic solutions to the offshore energy, defense, aerospace, manufacturing and entertainment industries. Most of Oceaneering's products are produced for the offshore oil and gas market. It had a 2020 segment realignment to promote synergies and cost efficiency. The five segments are subsea robotics; manufactured products; offshore projects group; integrity management and digital solutions; and aerospace and defense technologies. Within the segments are two businesses - services and products provided primarily to the oil and gas industry. The firm is also involved in the offshore renewables and mobility solutions industries.